Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study.

چکیده

To assess whether systemic prostacyclin analogue (PCA) therapy in patients with pulmonary arterial hypertension (PAH) is associated with a reduced long-term risk of developing age-related macular degeneration (AMD). A retrospective cohort study was conducted using the TriNetX global health research…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• دژنراسیون ماکولا